Tern Share Discussion Threads

[bcfc5] 20/11/2024 20:40

SteveInteresting 12 months ahead.Thankfully Sisto maybe CEO but now he is not a Director, we have 2 bright new Directors, who will have a say in the sale of Tern assets.I really would love Sisto to prove us wrong but his recent judgement, Pires, timing of dilutions and lack of communication do suggest that he is well past his sell by date

[steveberyl] 20/11/2024 19:37

Just to repeat for Newbies, Device Authority 3.4% was sold to Venafi as a STRATEGICAL STAKE by SISTO, not Darren Antill D/A CEO, but by Sisto of TERN

Tern gained absolutely NO material advantage. Antill must have been apoplectic when he learned of this, a third party getting access to DA/KS TECH.

That SALE at such a giveaway price meant the Multiplied price of DA/KS was considerably less and CONSEQUENTLY TERN PRICE FELL dramatically, ON A SALE?

Proving that SISTO is Brain Dead. This Sovereign Wealth disclosure and my own thoughts lead me to believe, our researchers have stumbled upon the whole SISTO SCHEME. A deal may be close, BUT IS IT THE DEAL WE WANT??.

MR MARKET does not trust our Snake oil Salesman, nor do I.

[jack ladd] 20/11/2024 19:25

No luv, there will be no MBO ya dimwit.

[cmackay] 20/11/2024 17:44

Tern is going bullish. I think it's going to be a strong surge.

[yusuf77] 20/11/2024 17:40

off topic-znt ready to take off not many shares only 38.69m shares in issue a share to get inearly 2 director buys last week ready to blow deal done

[kumala] 20/11/2024 17:33

Consolidation around this area is not bad, before another move up, better slowly and surely consoldating on way is ok.Now above 50 day moving average (1.52 and rising since circa 12th Nov) and 200 day moving average (1.83 and steady) RSI above average 50, now 58.88.Onwards and upwards.GLA:)

[wardy333] 20/11/2024 17:14

Blue days keep coming, 2p on the horizon, likely to make that the next few trading days if buying continues, needs an update from the investees, silence is deafening, but as someone said why has the new female Bod member not bought any, hope she is not like Payne she spent more on her nails than on Tern shares.
Is something happening to prevent the Bod buying in?

[tullynessle] 20/11/2024 16:56

Stent / 357669

Many thanks - I spent some time trying to trace "Baron Cars" with little success,

I notice that McLaren is now owned by "Mumtalakat Holding Company"


"In March 2024, Mumtalakat Holding Company, the sovereign wealth fund of the Kingdom of Bahrain acquired all outstanding shares of McLaren Group and took full control of the company.[12]"




----------------

[ebomber] 20/11/2024 16:51

SW

Beggars belief how few buttons DA is valued at if current Tern plc share price is a measure.

Welcome yet another day of incremental gains whilst this undervalued and oversold VC stock is under the radar of its true enterprise value.

Whispers from HNW individuals Tern plc is now a very cheap entry to gain sizeable stakes in DA, FvR and TM.

[still waiting] 20/11/2024 16:31

DA valued at buttons.

It’s a strange one.

[stentorian] 20/11/2024 16:22

McLaren - Darron previously mentioned that there was a champagne moment when all cars were simulataneous accessed OTA.

[tullynessle] 20/11/2024 16:11

Re Post 357667

I believe the reference to a car manufacturer who is a customer is Baron Cars, (the M before Baron is likely to be a hesitation - eg mm).

Baron Cars could refer to:

[tullynessle] 20/11/2024 16:06

Below is a copy of the transcript of the TERN Capital Markets Day Presentation held on March 27, 2024.

The extract is full of information including the following:

* ability to White Label

* really building ARR creating that value and this year you know as I said before we'll be looking to double if not triple our AR

* that's going to be down to the extent not just of new logo acquisition but how they move forward to production, production is where scale comes when they start rolling out to thousands they have a sign of devices

* they have to solve it in real real time on a regular basis throughout the life cycle of the product

* you know and we've talked like M Baron cars for example and others you know those they keep manufacturing new cars and that continues to build as a customer

* and you know last year we signed a 5-year contract with a leading medical company um and they are only now going to production so all the business we've done so far is to really advance and accelerate certain things they wanted to do and they now have up to 12 divisions that are looking to engage and buy into that platform that's their application and then connect the multiple of different devices that solve different problems whether it be in hospitals or other health care facilities and so you know the success of that project clearly could be lucrative for us but that's down to their success as they look to roll out those medical products and the beauty of our solution is you know we're retrofit



Extract - Transcript from 34:10 mins in to 36:34 mins in from the start.


34:10
job titles or the functions that you know people have either bought from us or that talked to us so this is all based on proof and reality not uh
34:18
Theory and and just building out um just to touch on our business model and you know whether it's key scaler or key
34:24
scaler as a service it's the same product once our cloud service which clearly we're delivering direct albeit
34:30
we do have the ability to White Label that to Partners and we do have some of those conversations where people would
34:35
look to offer it as their in extension of their offering but fundamentally our business model is subscription um so it
34:43
really building ARR creating that value and this year you know as I said before we'll be looking to double if not triple
34:49
our AR really and that's going to be down to the extent not just of new logo acquisition but how they move forward to
34:56
production production is where scale comes when they start rolling out to thousands they have a sign of devices
35:02
they have a significant problem that they could can't do with their teams and their people and they have to solve it
35:07
in real real time on a regular basis throughout the life cycle of the product you know and we've talked like M Baron
35:13
cars for example and others you know those they keep manufacturing new cars and that continues to build as a
35:19
customer um and that's just you know that's one good example of medical devices that roll out sometimes people
35:24
have devices in the field or they're bringing out new products and so that subscription builds as companies scale
35:31
and you know last year we signed a 5-year contract with a leading medical company um and they are only now going
35:38
to production so all the business we've done so far is to really advance and accelerate certain things they wanted to
35:44
do and they now have up to 12 divisions that are looking to engage and buy into that platform that's their iot
35:51
application and then connect the multiple of different devices that solve different problems whether it be in hospitals or other health care
35:57
facilities and so you know the success of that project clearly could be lucrative for us but that's down to
36:04
their success as they look to roll out those medical products and the beauty of our solution is you know we're retrofit
36:10
so we can deal with with infield as well as new products but subscription is the key um people buy a license they buy for
36:17
the base license they buy an incremental per device license and for the future products that we'll be adding in as
36:23
extra functionality there will be an additional license that we that people will pay for and I think the final point
36:29
on this I wanted to make is you know you should definitely think of us as agnostic um you know I go back to the
36:34
10-11 point uh we we work just because of the way we built our product and the......




TERN - Capital Markets Day Presentation March 2024

[tullynessle] 20/11/2024 15:55

Deleted - sent but not yet finished

[jonc] 20/11/2024 15:26

L2 under significant pressure.#factchecked.